NecstGen and ProteoNic report development of improved viral vectors through the application of premium 2G UNic™ technology

[ad_1] LEIDEN, the Netherlands, Sept. 19, 2023 /PRNewswire/ — Necstgen, a non-profit CDMO and ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics, announce…